Eisai Archives - Pharmaphorum

Biogen, Eisai hit hard as Alzheimer’s drug is abandoned

https://pharmaphorum.com/news/biogen-eisai-hit-hard-as-alzheimers-drug-is-abandoned/

Eisai, Takeda and GARDP hunt for new antibiotics

https://pharmaphorum.com/news/eisai-takeda-and-gardp-hunt-for-new-antibiotics/

Taking on the challenge of childhood epilepsy

https://pharmaphorum.com/r-d/views-analysis-r-d/taking-challenge-childhood-epilepsy/

Eisai/Merck & Co’s Lenvima approved in EU for first line liver cancer

https://pharmaphorum.com/news/eisai-merck-cos-lenvima-approved-in-eu-for-first-line-liver-cancer/

Biogen and Eisai Alzheimer’s drug excites doctors, but not investors

https://pharmaphorum.com/news/biogen-and-eisai-alzheimers-drug-excites-doctors-but-not-investors/

PureTech to research Alzheimer’s drugs based on ‘brain drain’ theory

https://pharmaphorum.com/news/puretech-research-alzheimers-brain-drain-theory/

Hope for Alzheimer’s treatment after promising study results

https://pharmaphorum.com/news/alzheimers-disease-promising-study/

Raising the bar in liver cancer therapy

https://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/

Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success

https://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/

Search